Elevance Health
ELV
1,516 hedge funds and large institutions have $96.9B invested in Elevance Health in 2023 Q1 according to their latest regulatory filings, with 133 funds opening new positions, 559 increasing their positions, 564 reducing their positions, and 132 closing their positions.
1% more first-time investments, than exits
New positions opened: 133 | Existing positions closed: 132
0.6% more ownership
Funds ownership: 89.19% → 89.78% (+0.6%)
1% less repeat investments, than reductions
Existing positions increased: 559 | Existing positions reduced: 564
2% less call options, than puts
Call options by funds: $424M | Put options by funds: $434M
2% less funds holding
Funds holding: 1,548 → 1,516 (-32)
10% less capital invested
Capital invested by funds: $108B → $96.9B (-$11.2B)
27% less funds holding in top 10
Funds holding in top 10: 67 → 49 (-18)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
+$1.26B |
| 2 |
DCP
D1 Capital Partners
New York
|
+$325M |
| 3 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$308M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$304M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$263M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$688M |
| 2 |
BlackRock
New York
|
-$339M |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$303M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$275M |
| 5 |
Neuberger Berman Group
New York
|
-$222M |
ELV Hedge Fund Activity: Q1 2023 in Review
1,516 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q1 2023, worth a combined $96.9B — down 10% from $108B a quarter earlier.
Buyers outnumbered sellers: 133 funds opened new ELV positions and 132 closed out — a net gain of 1 holder — while 559 added to existing stakes and 564 trimmed.
The largest buyer was Envestnet Asset Management, adding an estimated $1.26B. The largest seller was Fidelity Investments, cutting an estimated $688M.
- 1,516 institutional investors held Elevance Health (ELV) as of Q1 2023, down from 1,548 in Q4 2022.
- Funds reported $96.9B of Elevance Health stock for Q1 2023, down 10% quarter-over-quarter.
- 133 funds opened new Elevance Health positions in Q1 2023 and 132 closed out, a net change of +1 holder.
- The largest Elevance Health buyer in Q1 2023 was Envestnet Asset Management, an estimated $1.26B added.
- The largest Elevance Health seller in Q1 2023 was Fidelity Investments, an estimated $688M sold.
Based on aggregated 13F filings for Q1 2023.